$1.48
-0.15 (-9.20%)
Open$1.66
Previous Close$1.63
Day High$1.74
Day Low$1.46
52W High$4.15
52W Low$1.27
Volume—
Avg Volume231.9K
Market Cap55.62M
P/E Ratio3.56
EPS$0.44
SectorPharmaceuticals
Analyst Ratings
Strong Buy
11 analysts
Price Target
+1,029.1% upside
Current
$1.48
$1.48
Target
$16.71
$16.71
$12.81
$16.71 avg
$20.08
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 127.89M | 121.54M | 22.38M |
| Net Income | 17.99M | 15.39M | 3.27M |
| Profit Margin | 14.1% | 13.4% | 14.6% |
| EBITDA | 24.98M | 22.56M | 5.70M |
| Free Cash Flow | — | — | 2.62M |
| Rev Growth | +5.2% | +5.2% | -5.1% |
| Debt/Equity | 9.02 | 9.02 | 0.18 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |